Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit.
about
A Case-Control Study Brings to Light the Causes of Screen Failures in Phase 1 Cancer Clinical TrialsAntiangiogenesis and gene aberration-related therapy may improve overall survival in patients with concurrent KRAS and TP53 hotspot mutant cancerFinancial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity ProgramContinuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience.Recognizing the Financial Burden of Cancer Patients in Clinical Trials.Enrollment in early-phase clinical trials in pediatric oncology: The experience at Institut Curie.
P2860
Barriers to study enrollment in patients with advanced cancer referred to a phase I clinical trials unit.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Barriers to study enrollment i ...... phase I clinical trials unit.
@en
Barriers to study enrollment i ...... phase I clinical trials unit.
@nl
type
label
Barriers to study enrollment i ...... phase I clinical trials unit.
@en
Barriers to study enrollment i ...... phase I clinical trials unit.
@nl
prefLabel
Barriers to study enrollment i ...... phase I clinical trials unit.
@en
Barriers to study enrollment i ...... phase I clinical trials unit.
@nl
P2093
P2860
P50
P1433
P1476
Barriers to study enrollment i ...... phase I clinical trials unit.
@en
P2093
Adrienne Howard
David S Hong
Gerald S Falchook
Jennifer J Wheler
Lacey McQuinn
Ralph Zinner
Sarina A Piha-Paul
P2860
P304
P356
10.1634/THEONCOLOGIST.2013-0202
P577
2013-10-23T00:00:00Z